Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2011

01-05-2011 | Original Article

Incidence of Esophageal Carcinoma Among Malays in North-Eastern Peninsular Malaysia: An Area with an Exceptionally Low Prevalence of Helicobacter pylori Infection

Authors: Yeong Yeh Lee, S. Mahendra Raj, Sharifah Emilia Tuan Sharif, Rosemi Salleh, Mukarramah Che Ayub, David Y. Graham

Published in: Digestive Diseases and Sciences | Issue 5/2011

Login to get access

Abstract

Background

Obesity, gastroesophageal reflux, and Barrett’s esophagus have all been linked to esophageal adenocarcinoma. In addition, the decline in Helicobacter pylori (H. pylori) infection in affluent societies has also been suggested to be a major factor in the recent rise in the incidence of esophageal adenocarcinoma. If H. pylori infection has a protective role, populations with a naturally low prevalence of H. pylori infection such as the ethnic Malays of Northeastern Peninsular Malaysia should have high rates of esophageal adenocarcinoma.

Aim

To test this hypothesis, we investigated the incidence of esophageal carcinoma among the ethnic Malays of the state of Kelantan in Northeastern Peninsular Malaysia.

Methods

The pathology services in the state of Kelantan are provided by two main hospitals. The histopathological records of both hospitals were systematically examined to retrieve all cases of esophageal carcinoma diagnosed between 2004 and 2008. Incidence rates were determined based on the most recent population census.

Results

The age-standardized incidence rates (per 100,000 population) of esophageal adenocarcinoma among Malay men and women were 0.75 and 0.69, respectively. The corresponding rates for squamous cell carcinoma of the esophagus were 0.66 and 1.34, respectively.

Conclusions

The low rates of adenocarcinoma and squamous cell carcinoma of the esophagus in the study area, despite the fact that H. pylori infection is virtually absent, does not support the hypothesis that the absence of H. pylori infection is a pivotal factor in the pathogenesis of these cancers.
Literature
1.
go back to reference DeMeester SR. Epidemiology and biology of esophageal cancer. Gastrointest Cancer Res. 2009;3:S2–S5.PubMed DeMeester SR. Epidemiology and biology of esophageal cancer. Gastrointest Cancer Res. 2009;3:S2–S5.PubMed
2.
go back to reference Liu Y, Akiyama J, Graham DY. Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease. Minerva Gastroenterol Dietol. 2006;52:235–248.PubMed Liu Y, Akiyama J, Graham DY. Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease. Minerva Gastroenterol Dietol. 2006;52:235–248.PubMed
3.
go back to reference Graham DY. The changing epidemiology of GERD: Geography and Helicobacter pylori. Am J Gastroenterol. 2003;98:1462–1470.PubMedCrossRef Graham DY. The changing epidemiology of GERD: Geography and Helicobacter pylori. Am J Gastroenterol. 2003;98:1462–1470.PubMedCrossRef
4.
go back to reference Richter JE, Falk GW, Vaezi MF. Helicobacter pylori and gastroesophageal reflux disease: The bug may not be all bad. Am J Gastroenterol. 1998;93:1800–1802.PubMedCrossRef Richter JE, Falk GW, Vaezi MF. Helicobacter pylori and gastroesophageal reflux disease: The bug may not be all bad. Am J Gastroenterol. 1998;93:1800–1802.PubMedCrossRef
5.
go back to reference Rokkas T, Pistioloas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol. 2007;5:1413–1417.PubMedCrossRef Rokkas T, Pistioloas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol. 2007;5:1413–1417.PubMedCrossRef
6.
go back to reference Henrik Siman J, Forsgren A, Berglund G, Floren CH. Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter. 2001;6:310–316.PubMedCrossRef Henrik Siman J, Forsgren A, Berglund G, Floren CH. Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter. 2001;6:310–316.PubMedCrossRef
7.
go back to reference Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: A meta-analysis. Cancer Prev Res (Phila). 2008;1:329–338.CrossRef Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: A meta-analysis. Cancer Prev Res (Phila). 2008;1:329–338.CrossRef
8.
go back to reference Ye W, held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004;96:388–396.PubMedCrossRef Ye W, held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004;96:388–396.PubMedCrossRef
9.
go back to reference Uyub AM, Raj SM, Visvanathan M, Nazim M, Aiyar S, Anuar AK. Helicobacter pylori infection in Northeastern Peninsular Malaysia: Evidence for an unusually low prevalence. Scand J Gastroenterol. 1994;29:209–213.PubMedCrossRef Uyub AM, Raj SM, Visvanathan M, Nazim M, Aiyar S, Anuar AK. Helicobacter pylori infection in Northeastern Peninsular Malaysia: Evidence for an unusually low prevalence. Scand J Gastroenterol. 1994;29:209–213.PubMedCrossRef
10.
go back to reference Mahendra Raj S, Yap K, Haq JA, Singh S, Hamid A. Further evidence for an exceptionally low prevalence of Helicobacter pylori infection among peptic ulcer patients in north-eastern peninsular Malaysia. Trans R Soc Trop Med Hyg. 2001;95:24–27.CrossRef Mahendra Raj S, Yap K, Haq JA, Singh S, Hamid A. Further evidence for an exceptionally low prevalence of Helicobacter pylori infection among peptic ulcer patients in north-eastern peninsular Malaysia. Trans R Soc Trop Med Hyg. 2001;95:24–27.CrossRef
11.
go back to reference Radzi M, Mahendra Raj S. The incidence of gastric carcinoma in Kelantan, Malaysia is the lowest reported in the world. Med J Malaysia. 2000;55(Suppl A):13. Radzi M, Mahendra Raj S. The incidence of gastric carcinoma in Kelantan, Malaysia is the lowest reported in the world. Med J Malaysia. 2000;55(Suppl A):13.
12.
go back to reference Population census statistics of Kelantan from 2004–2008. Department of Statistics, Malaysia 2009. Population census statistics of Kelantan from 2004–2008. Department of Statistics, Malaysia 2009.
13.
go back to reference Omar BA, Cynthia BP, Alan DL, CJL Murray, Rafael L, Mie I. Age Standardization of Rates: A New WHO Standard. GPE Discussion Paper Series. WHO; 31:1–14. Omar BA, Cynthia BP, Alan DL, CJL Murray, Rafael L, Mie I. Age Standardization of Rates: A New WHO Standard. GPE Discussion Paper Series. WHO; 31:1–14.
14.
go back to reference Fernandes ML, Seow A, Chan YH, Ho KY. Opposing trends in incidence of esophageal squamous carcinoma and adenocarcinoma in a multi-ethnic Asian country. Am J Gastroenterol. 2006;101:1430–1436.PubMedCrossRef Fernandes ML, Seow A, Chan YH, Ho KY. Opposing trends in incidence of esophageal squamous carcinoma and adenocarcinoma in a multi-ethnic Asian country. Am J Gastroenterol. 2006;101:1430–1436.PubMedCrossRef
15.
go back to reference Shibata A, Matsuda T, Ajiki W, Sobue T. Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993–2001. Jpn J Clin Oncol. 2008;38:464–468.PubMedCrossRef Shibata A, Matsuda T, Ajiki W, Sobue T. Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993–2001. Jpn J Clin Oncol. 2008;38:464–468.PubMedCrossRef
16.
go back to reference Wu X, Chen VW, Ruiz B, Andrews P, Su LJ, Correa P. Incidence of esophageal and gastric carcinomas among American asians/Pacific Islanders, Whites and Balcks Subsite and histology differences. Cancer. 2006;106:683–692.PubMedCrossRef Wu X, Chen VW, Ruiz B, Andrews P, Su LJ, Correa P. Incidence of esophageal and gastric carcinomas among American asians/Pacific Islanders, Whites and Balcks Subsite and histology differences. Cancer. 2006;106:683–692.PubMedCrossRef
17.
go back to reference Wu X, Chen VW, Andrews P, Ruiz B, Correa P. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Causes Control. 2007;18:585–593.PubMedCrossRef Wu X, Chen VW, Andrews P, Ruiz B, Correa P. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Causes Control. 2007;18:585–593.PubMedCrossRef
18.
go back to reference Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol. 2008;103:2694–2699.PubMedCrossRef Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol. 2008;103:2694–2699.PubMedCrossRef
19.
go back to reference Ergor G. Esophageal cancer. In Cancer Incidence in four member countries of the Middle East Cancer Consortium (Cyprus, Egypt, Israel, Jordan) compared with US SEER. In: Freedman LS, Edwards BK, Ries LAG, Young JL, eds. National Cancer Institute. NIH Pub No. 06-5873. Bethasda, MD; Ch2; 29–33. Ergor G. Esophageal cancer. In Cancer Incidence in four member countries of the Middle East Cancer Consortium (Cyprus, Egypt, Israel, Jordan) compared with US SEER. In: Freedman LS, Edwards BK, Ries LAG, Young JL, eds. National Cancer Institute. NIH Pub No. 06-5873. Bethasda, MD; Ch2; 29–33.
21.
go back to reference Nakajima S, Hattori T. Active and inactive gastroesophageal reflux diseases related to Helicobacter pylori therapy. Helicobacter. 2003;8:279–293.PubMedCrossRef Nakajima S, Hattori T. Active and inactive gastroesophageal reflux diseases related to Helicobacter pylori therapy. Helicobacter. 2003;8:279–293.PubMedCrossRef
22.
go back to reference Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH. Is there increased risk of GERD after helicobacter pylori eradication?: A meta-analysis. Am J Gastroenterol. 2010;105:1007–1013.PubMedCrossRef Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH. Is there increased risk of GERD after helicobacter pylori eradication?: A meta-analysis. Am J Gastroenterol. 2010;105:1007–1013.PubMedCrossRef
23.
go back to reference Nazri SM, Imran MK, Ismail IM, Faris AA. Prevalence of overweight and self-reported chronic diseases among residents in Pulau Kundur, Kelantan, Malaysia. Southeast Asian J Trop Med Public health. 2008;39:162–167.PubMed Nazri SM, Imran MK, Ismail IM, Faris AA. Prevalence of overweight and self-reported chronic diseases among residents in Pulau Kundur, Kelantan, Malaysia. Southeast Asian J Trop Med Public health. 2008;39:162–167.PubMed
24.
go back to reference Shneider H, Dietrich ES, venetz WP. Trends and stabilization up tp 2022 in overweight and obesity in Switzerland, Comparison to France, UK, US and Australia. Int J Environ Res Public Health. 2010;7:460–472.CrossRef Shneider H, Dietrich ES, venetz WP. Trends and stabilization up tp 2022 in overweight and obesity in Switzerland, Comparison to France, UK, US and Australia. Int J Environ Res Public Health. 2010;7:460–472.CrossRef
25.
go back to reference Lee YY, Mustaffa N, Tuan Sharif, SE, Syed Aziz SH, Raj SM. Barrett’s oesophagus in an area with an exceptionally low prevalence of Helicobacter pylori. J Gastroenterol Hepatol. 2010;25(Suppl 2);A131. Lee YY, Mustaffa N, Tuan Sharif, SE, Syed Aziz SH, Raj SM. Barrett’s oesophagus in an area with an exceptionally low prevalence of Helicobacter pylori. J Gastroenterol Hepatol. 2010;25(Suppl 2);A131.
26.
go back to reference Kamanger F, Chow WH, Abnet CC, Dawsey SM. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009;38:27–57.CrossRef Kamanger F, Chow WH, Abnet CC, Dawsey SM. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009;38:27–57.CrossRef
27.
go back to reference Naing NN, Ahmad Z. Factors related to smoking habits of male secondary school teachers. Southeast Asian J Trop med Public health. 2001;32:434–439.PubMed Naing NN, Ahmad Z. Factors related to smoking habits of male secondary school teachers. Southeast Asian J Trop med Public health. 2001;32:434–439.PubMed
28.
go back to reference Beni-Hani KE, Shatnawi NJ, El Qaderi S, Khader YS, Bani-Hani BK. Prevealence and risk factors of Helicobacter pylori infection in healthy schoolchildren. Chin J Dig Dis. 2006;7:55–60.CrossRef Beni-Hani KE, Shatnawi NJ, El Qaderi S, Khader YS, Bani-Hani BK. Prevealence and risk factors of Helicobacter pylori infection in healthy schoolchildren. Chin J Dig Dis. 2006;7:55–60.CrossRef
29.
go back to reference Mohammad MA, Hussein L, Coward A, Jackson SJ. Prevalence of Helicobacter pylori infection among Egyptian children: Impact of social background and effect on growth. Public Health Nutr. 2008;11:30–36.CrossRef Mohammad MA, Hussein L, Coward A, Jackson SJ. Prevalence of Helicobacter pylori infection among Egyptian children: Impact of social background and effect on growth. Public Health Nutr. 2008;11:30–36.CrossRef
30.
go back to reference Katsunori I, Tomoyuk K, Yasuhiko A, et al. Extensive gastric atrophy: An increase risk factor for superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol. 2007;102:1603–1609.CrossRef Katsunori I, Tomoyuk K, Yasuhiko A, et al. Extensive gastric atrophy: An increase risk factor for superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol. 2007;102:1603–1609.CrossRef
31.
go back to reference Wu DC, Wu IC, Lee JM, et al. Helicobacter pylori infection: a protective factor for esophageal squamous carcinoma in a Taiwanese population. Am J Gastroenterol. 2005;100:588–593.PubMedCrossRef Wu DC, Wu IC, Lee JM, et al. Helicobacter pylori infection: a protective factor for esophageal squamous carcinoma in a Taiwanese population. Am J Gastroenterol. 2005;100:588–593.PubMedCrossRef
33.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef
34.
go back to reference Bray F, Guilloux A, Sankila R, Parkin DM. Practical implications of imposing a new world standard population. Cancer Causes and Control. 2002;13:175–182.PubMedCrossRef Bray F, Guilloux A, Sankila R, Parkin DM. Practical implications of imposing a new world standard population. Cancer Causes and Control. 2002;13:175–182.PubMedCrossRef
35.
go back to reference Pearce N. Editorial: The ecological fallacy strikes back. J Epidemiol Community Health. 2000;54:326–327.PubMedCrossRef Pearce N. Editorial: The ecological fallacy strikes back. J Epidemiol Community Health. 2000;54:326–327.PubMedCrossRef
Metadata
Title
Incidence of Esophageal Carcinoma Among Malays in North-Eastern Peninsular Malaysia: An Area with an Exceptionally Low Prevalence of Helicobacter pylori Infection
Authors
Yeong Yeh Lee
S. Mahendra Raj
Sharifah Emilia Tuan Sharif
Rosemi Salleh
Mukarramah Che Ayub
David Y. Graham
Publication date
01-05-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1473-1

Other articles of this Issue 5/2011

Digestive Diseases and Sciences 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine